BioNet is a biotechnology company dedicated to vaccine development and manufacturing of genetically designed vaccines. As the world’s only company to produce licensed recombinant pertussis vaccines containing genetically inactivated pertussis toxin (PTgen), BioNet demonstrates innovation across the entire lifecycle of vaccine development and commercialization.
Expanding its innovation capabilities, BioNet is advancing next-generation vaccines using cutting-edge mRNA technology platform. This includes the development of a pancoronavirus mRNA vaccine and other groundbreaking candidates designed to address critical public health needs.
Headquartered in Bangkok and Lyon, BioNet operates a state-of-the-art vaccine manufacturing facility in Ayutthaya, Thailand. With a strong foundation in R&D and manufacturing, our team of over 200 professionals is devoted to producing high-quality vaccines to combat re-emerging and pandemic diseases, shaping the future of global health.
Our Vision
Our Mission
Quality Policy
Message from the Chief Executive Officer
Dear colleagues,
BioNet’s mission is to develop, manufacture and supply vaccines using innovative technology platforms.
BioNet is guided by six core values.
- Passion – we live our passion at work.
- Excellence – we aim for excellence in quality and ethics.
- Respect – we respect others as we wish to be respected.
- Teamwork – we do better together.
- Innovation – we have an innovative mindset.
- Commitment – we commit to what we promise.
These values are at the heart of everything we do. They define this code of conduct, guide us towards the achievement of our ambitious mission and enable us to work as a high performing team. Our values help define us, build trust with our partners, and direct us to do the right thing every day. We should demonstrate our values in our interactions with others, and be held to account against them. It is up to each and every one of us to make BioNet the kind of organization we can all be proud of.
BioNet is committed to achieving the highest standards possible in our activities, and ensuring they meet the expectations of our partners, funders, other stakeholders, and the public. All decision-making and actions related to selecting external partners will be impartial and unbiased, meaning BioNet will be open, fair, and non-discriminatory in engaging with all external partners.
Our people are our most important asset and the key to BioNet’s success. We encourage a culture that embraces inclusiveness, respect, accountability, and opportunities for continuous improvement. In addition to the existing Employees Rules of Work and policies in research, clinical development, manufacturing, safety, quality, IT, sales, marketing, distribution, legal and financial reporting, currently in place, this Code of Conduct defines the standards we expect our employees and consultants to follow. And, we expect partners and suppliers to adhere to the same high standards.
If you have concerns regarding breaches of this Code of Conduct, please report such breaches immediately through our designated channels. We rely on you to help make sure that BioNet is aware of and can correct any issues that may not be in line with our high ethical standards.
I am proud to work with all of you.
Hong Thai Pham
CEO, BioNet